PMID- 24810146 OWN - NLM STAT- MEDLINE DCOM- 20150909 LR - 20220409 IS - 1878-0210 (Electronic) IS - 1878-0210 (Linking) VI - 9 IP - 1 DP - 2015 Feb TI - Meta-analysis of Atherogenic Index of Plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus. PG - 60-7 LID - S1751-9918(14)00044-8 [pii] LID - 10.1016/j.pcd.2014.03.007 [doi] AB - AIMS: Diabetic dyslipidemia is one of important complication of type 2 diabetes mellitus (T2DM). Blood lipid parameters (e.g., triglyceride, TG; total cholesterol, TC; high-density lipoprotein cholesterol, HDL-C; low-density lipoprotein cholesterol, LDL-C; Atherogenic Index of Plasma defined as lg(TG/HDL-C), AIP), are important indexes in predicting risk of T2DM. This study performed comprehensive meta-analyses to evaluate the powers of these indexes, especially for AIP, on predicting risk of T2DM. METHODS: We searched PubMed Database, China National Knowledge Infrastructure (CNKI) and Wanfang Database in February 2014 to identify eligible studies. Case-control studies that have mean baseline values of AIP were included. Random-effect models were used to pool the summary standardized mean difference (SMD) in meta-analysis. RESULTS: Fifteen eligible studies, with a total sample size of 4010, were included in meta-analysis. All these studies reported positive associations between AIP and T2DM. Moreover, the SMD for the AIP is 1.78 (95% confidence interval (CI): 1.04-2.52), which is higher than for other parameters (TG: 0.93, 95% CI: 0.78-1.09; TC: 0.46, 95% CI: 0.21-0.71; HDL-C: -0.89, 95% CI: -1.18 to -0.60; and LDL-C: 0.44, 95% CI: 0.11-0.77). Meta-analysis of association between BMI and T2DM gave a SMD of 0.85 (95% CI: 0.38 to 1.32). CONCLUSIONS: The results suggest that lipid parameters have ability to reflect the risk of T2DM, but AIP may be more closely associated with the risk of T2DM. The current results suggest AIP may be used as a simple, easily calculated parameter in assessing the risk of T2DM. CI - Copyright (c) 2014 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved. FAU - Zhu, Xiao-Wei AU - Zhu XW AD - Center for Genetic Epidemiology and Genomics, School of Public Health, Soochow University, Suzhou, Jiangsu 215123, PR China; Department of Epidemiology, School of Public Health, Soochow University, Suzhou, Jiangsu 215123, PR China. FAU - Deng, Fei-Yan AU - Deng FY AD - Center for Genetic Epidemiology and Genomics, School of Public Health, Soochow University, Suzhou, Jiangsu 215123, PR China; Department of Epidemiology, School of Public Health, Soochow University, Suzhou, Jiangsu 215123, PR China. FAU - Lei, Shu-Feng AU - Lei SF AD - Center for Genetic Epidemiology and Genomics, School of Public Health, Soochow University, Suzhou, Jiangsu 215123, PR China; Department of Epidemiology, School of Public Health, Soochow University, Suzhou, Jiangsu 215123, PR China. Electronic address: leishufeng@yahoo.com. LA - eng PT - Journal Article PT - Meta-Analysis PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20140505 PL - England TA - Prim Care Diabetes JT - Primary care diabetes JID - 101463825 RN - 0 (Biomarkers) RN - 0 (Lipids) SB - IM MH - Atherosclerosis/*blood/diagnosis/epidemiology MH - Biomarkers/blood MH - Body Mass Index MH - Diabetes Mellitus, Type 2/*blood/diagnosis/epidemiology MH - Dyslipidemias/*blood/diagnosis/epidemiology MH - Humans MH - Lipids/*blood MH - Prognosis MH - Risk Assessment MH - Risk Factors OTO - NOTNLM OT - Atherogenic Index of Plasma OT - Lipid parameter OT - Meta-analysis OT - Type 2 diabetes mellitus EDAT- 2014/05/09 06:00 MHDA- 2015/09/10 06:00 CRDT- 2014/05/10 06:00 PHST- 2013/12/16 00:00 [received] PHST- 2014/03/05 00:00 [revised] PHST- 2014/03/26 00:00 [accepted] PHST- 2014/05/10 06:00 [entrez] PHST- 2014/05/09 06:00 [pubmed] PHST- 2015/09/10 06:00 [medline] AID - S1751-9918(14)00044-8 [pii] AID - 10.1016/j.pcd.2014.03.007 [doi] PST - ppublish SO - Prim Care Diabetes. 2015 Feb;9(1):60-7. doi: 10.1016/j.pcd.2014.03.007. Epub 2014 May 5.